{"id":"https://openalex.org/W2129497554","doi":"https://doi.org/10.1158/1535-7163.mct-06-0145","title":"Chronic hypoxia promotes hypoxia-inducible factor-1\u03b1\u2013dependent resistance to etoposide and vincristine in neuroblastoma cells","display_name":"Chronic hypoxia promotes hypoxia-inducible factor-1\u03b1\u2013dependent resistance to etoposide and vincristine in neuroblastoma cells","alternate_titles":[],"publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2129497554","doi":"https://doi.org/10.1158/1535-7163.mct-06-0145","mag":"2129497554","pmid":"https://pubmed.ncbi.nlm.nih.gov/16985058"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-06-0145","doi":"https://doi.org/10.1158/1535-7163.mct-06-0145","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0145","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129497554"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003557151","display_name":"Deema M. Hussein","orcid":"https://orcid.org/0000-0002-8316-489X","observed_orcids":["https://orcid.org/0000-0002-8316-489X"]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deema Hussein","raw_affiliation_strings":["1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;","institution_ids":["https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111736998","display_name":"Edward J. Estlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward J. Estlin","raw_affiliation_strings":["2Department of Paediatric Oncology, Royal Manchester Children's Hospital; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Paediatric Oncology, Royal Manchester Children's Hospital; and","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039337111","display_name":"Caroline Dive","orcid":"https://orcid.org/0000-0002-1726-8850","observed_orcids":["https://orcid.org/0000-0002-1726-8850"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Caroline Dive","raw_affiliation_strings":["1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;","3Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;","institution_ids":["https://openalex.org/I4210129527"]},{"raw_affiliation_string":"3Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036070143","display_name":"Guy Makin","orcid":"https://orcid.org/0000-0003-3513-3957","observed_orcids":["https://orcid.org/0000-0003-3513-3957"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guy W.J. Makin","raw_affiliation_strings":["1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;","2Department of Paediatric Oncology, Royal Manchester Children's Hospital; and","3Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cellular and Molecular Pharmacology, Paterson Institute for Cancer Research;","institution_ids":["https://openalex.org/I4210129527"]},{"raw_affiliation_string":"2Department of Paediatric Oncology, Royal Manchester Children's Hospital; and","institution_ids":["https://openalex.org/I4210160221"]},{"raw_affiliation_string":"3Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4452,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.89534033,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"5","issue":"9","first_page":"2241","last_page":"2250"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.030400000512599945,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.8220000267028809},{"id":"https://openalex.org/keywords/etoposide-resistance","display_name":"etoposide resistance","score":0.8259999752044678},{"id":"https://openalex.org/keywords/vincristine-resistance","display_name":"vincristine resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9200000166893005},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6110000014305115},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.9919999837875366},{"id":"https://openalex.org/keywords/carbonic-anhydrase-ix","display_name":"carbonic anhydrase IX","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hif-1alpha-stabilization","display_name":"HIF-1\u03b1 stabilization","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hif-1alpha-inhibition","display_name":"HIF-1\u03b1 inhibition","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.8024029731750488},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.7231712341308594},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6501265168190002},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.6417354941368103},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5623555779457092},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4744128882884979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44703853130340576},{"id":"https://openalex.org/C160450060","wikidata":"https://www.wikidata.org/wiki/Q104598479","display_name":"Hypoxia-inducible factors","level":3,"score":0.4364425837993622},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3976290822029114},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3379155993461609},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3310961127281189},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2266746461391449},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17026454210281372},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1330455243587494},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.11172392964363098},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10192534327507019},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.06127235293388367},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051795","descriptor_name":"Hypoxia-Inducible Factor 1, alpha Subunit","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051795","descriptor_name":"Hypoxia-Inducible Factor 1, alpha Subunit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051795","descriptor_name":"Hypoxia-Inducible Factor 1, alpha Subunit","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-06-0145","doi":"https://doi.org/10.1158/1535-7163.mct-06-0145","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0145","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:16985058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16985058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/5f5bf3cd-d8a0-4daa-a850-d92f7da54339","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/5f5bf3cd-d8a0-4daa-a850-d92f7da54339","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hussein, D, Estlin, E, Makin, GWJ & Dive, C 2006, 'Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells.', Mol Cancer Ther, vol. 5( 9).","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/bc44c433-e400-4873-b761-5198cde06e7e","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/bc44c433-e400-4873-b761-5198cde06e7e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hussein, D, Estlin, E J, Dive, C & Makin, G W J 2006, 'Chronic hypoxia promotes hypoxia-inducible factor-1-\u03b1-dependent resistance to etoposide and vincristine in neuroblastoma cells', Molecular Cancer Therapeutics, vol. 5, no. 9, pp. 2241-2250. https://doi.org/10.1158/1535-7163.MCT-06-0145","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1493048246","https://openalex.org/W1749022239","https://openalex.org/W1844723954","https://openalex.org/W1959188680","https://openalex.org/W1963674319","https://openalex.org/W1965546606","https://openalex.org/W1970832400","https://openalex.org/W1971917580","https://openalex.org/W1972032694","https://openalex.org/W1972783950","https://openalex.org/W1976605228","https://openalex.org/W1976880272","https://openalex.org/W1977242675","https://openalex.org/W1985111376","https://openalex.org/W1996830477","https://openalex.org/W2000175408","https://openalex.org/W2022501326","https://openalex.org/W2023799373","https://openalex.org/W2030575063","https://openalex.org/W2047688922","https://openalex.org/W2060480804","https://openalex.org/W2062264756","https://openalex.org/W2065697804","https://openalex.org/W2075188232","https://openalex.org/W2082662034","https://openalex.org/W2083450219","https://openalex.org/W2085609942","https://openalex.org/W2099635275","https://openalex.org/W2100970398","https://openalex.org/W2114005496","https://openalex.org/W2125257427","https://openalex.org/W2131310342","https://openalex.org/W2137371083","https://openalex.org/W2144243712","https://openalex.org/W2144625075","https://openalex.org/W2146270900","https://openalex.org/W2148419067","https://openalex.org/W2156961194","https://openalex.org/W2160664949","https://openalex.org/W2161336519","https://openalex.org/W2236820229","https://openalex.org/W2327522594","https://openalex.org/W4293162689"],"related_works":["https://openalex.org/W2097669240","https://openalex.org/W2766115801","https://openalex.org/W1990418094","https://openalex.org/W2404245781","https://openalex.org/W2137933268","https://openalex.org/W2762032212","https://openalex.org/W2149823628","https://openalex.org/W2021381932","https://openalex.org/W2056241899"],"abstract_inverted_index":{"Hypoxia":[0],"is":[1,44],"widespread":[2],"in":[3,20,51,111,116,125,146,155,214,227,231],"solid":[4],"tumors":[5],"as":[6],"a":[7,21],"consequence":[8],"of":[9,16,23,49,59,64,83,87,103,162,172,175,186],"poorly":[10],"structured":[11],"tumor-derived":[12],"neovasculature.":[13],"Direct":[14],"measurement":[15],"low":[17],"oxygen":[18],"levels":[19],"range":[22],"adult":[24],"tumor":[25,29],"types":[26],"has":[27],"correlated":[28],"hypoxia":[30,50,60,84,102,136,163,206],"with":[31],"advanced":[32],"stage,":[33],"poor":[34,41],"response":[35,63,143],"to":[36,72,89,105,109,144,181,208,210],"chemotherapy":[37],"and":[38,40,70,79,113,118,121,193,216],"radiotherapy,":[39],"prognosis.":[42],"Little":[43],"known":[45],"about":[46],"the":[47,57,62,65,73,141,194],"importance":[48],"pediatric":[52],"tumors;":[53],"therefore,":[54],"we":[55],"evaluated":[56],"effects":[58],"on":[61,95,140],"neuroblastoma":[66,215],"cell":[67,157],"lines":[68,158],"SH-EP1":[69,119],"SH-SY5Y":[71,117,147],"clinically":[74,211],"relevant":[75,212],"drugs,":[76],"vincristine,":[77],"etoposide,":[78],"cisplatin.":[80],"Short":[81],"periods":[82],"(1%":[85],"O2)":[86],"up":[88],"16":[90],"hours":[91,161,171],"had":[92,137],"no":[93,166],"effect":[94,139],"drug-induced":[96],"apoptosis":[97,115],"or":[98],"clonogenic":[99,127,142],"survival.":[100],"Prolonged":[101],"1":[104],"7":[106],"days":[107],"leads":[108,207],"reduction":[110],"vincristine-":[112],"etoposide-induced":[114],"cells,":[120],"this":[122,232],"was":[123,153,165],"reflected":[124],"increased":[126],"survival":[128],"under":[129],"these":[130,156],"conditions.":[131],"Neither":[132],"short-term":[133],"nor":[134],"prolonged":[135,205],"any":[138],"cisplatin":[145],"cells.":[148],"Hypoxia-inducible":[149],"factor-1":[150],"(HIF-1)":[151],"alpha":[152],"stabilized":[154],"within":[159],"2":[160],"but":[164],"longer":[167],"detectable":[168],"beyond":[169],"48":[170],"hypoxia.":[173],"Up-regulation":[174],"carbonic":[176],"anhydrase":[177],"IX":[178],"showed":[179],"HIF-1alpha":[180,187,222],"be":[182,225],"transcriptionally":[183],"active.":[184],"Down-regulation":[185],"by":[188],"short":[189],"hairpin":[190],"RNA":[191],"interference":[192],"small-molecule":[195],"3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole":[196],"reduced":[197],"hypoxia-induced":[198],"drug":[199,229],"resistance.":[200],"These":[201],"results":[202],"suggest":[203],"that":[204,217],"resistance":[209,230],"drugs":[213],"therapies":[218],"aimed":[219],"at":[220],"inhibiting":[221],"function":[223],"may":[224],"useful":[226],"overcoming":[228],"tumor.":[233]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129497554","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
